IMS Health Holdings Inc. (NYSE:IMS) has received a consensus rating of “Buy” from the nine analysts that are presently covering the company. Three research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $30.67.

IMS has been the topic of several research analyst reports. Zacks Investment Research raised shares of IMS Health Holdings from a “hold” rating to a “buy” rating and set a $34.00 target price on the stock in a research note on Wednesday, September 28th. TheStreet lowered shares of IMS Health Holdings from a “buy” rating to a “hold” rating in a research report on Monday, August 29th.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Acrospire Investment Management LLC boosted its position in shares of IMS Health Holdings by 31.3% in the second quarter. Acrospire Investment Management LLC now owns 4,200 shares of the company’s stock valued at $107,000 after buying an additional 1,000 shares during the last quarter. Nordea Investment Management AB boosted its position in shares of IMS Health Holdings by 9.3% in the second quarter. Nordea Investment Management AB now owns 4,811 shares of the company’s stock valued at $122,000 after buying an additional 411 shares during the last quarter. Daiwa Securities Group Inc. boosted its position in shares of IMS Health Holdings by 11.4% in the third quarter. Daiwa Securities Group Inc. now owns 3,900 shares of the company’s stock valued at $122,000 after buying an additional 400 shares during the last quarter. LS Investment Advisors LLC boosted its position in shares of IMS Health Holdings by 14.0% in the second quarter. LS Investment Advisors LLC now owns 4,982 shares of the company’s stock valued at $126,000 after buying an additional 611 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its position in shares of IMS Health Holdings by 83.8% in the second quarter. BNP Paribas Arbitrage SA now owns 4,993 shares of the company’s stock valued at $127,000 after buying an additional 2,276 shares during the last quarter. Institutional investors own 90.25% of the company’s stock.

IMS Health Holdings (NYSE:IMS) opened at 31.34 on Monday. IMS Health Holdings has a 12 month low of $22.36 and a 12 month high of $31.34. The company’s 50-day moving average is $31.22 and its 200 day moving average is $28.38.

About IMS Health Holdings

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

5 Day Chart for NYSE:IMS

Receive News & Stock Ratings for IMS Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc. and related stocks with our FREE daily email newsletter.